Skip to main content

Paul G. Saleeb, MD

Academic Title:

Assistant Professor

Primary Appointment:

Medicine

Administrative Title:

Chief, Medical Critical Care Services

Location:

IHV N345

Phone (Primary):

(410) 706-3394

Fax:

(410) 706-1992

Education and Training

 

 

Medical School:       University of Texas Southwestern Medical Center at Dallas

                                       M.D., 2004

 

Residency:                Georgetown University Hospital

                                      Internal Medicine, 2007

 

Fellowship:               National Institute of Allergy and Infectious Diseases

                                      National Institutes of Health

                                      Infectious Diseases, 2012

Biosketch

Dr. Saleeb attended medical school at the University of Texas Southwestern Medical Center at Dallas then completed his residency in internal medicine at Georgetown University Hospital. Before training in infectious diseases at the National Institutes of Health (NIH), he was a volunteer physician in Nairobi, Kenya and the Nuba Mountains, Sudan. At the NIH his research included developing and testing a protocol for rapid identification of mycobacteria using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). He also conducted research in Mali on the microscopic-observation drug-susceptibility (MODS) assay for diagnosis and drug susceptibility testing of tuberculosis.

Dr. Saleeb joined the Institute of Human Virology (IHV) in 2012. He is currently the chief of infectious diseases services in the medical intensive care unit.  In addition to clinical service at the University of Maryland, he provides consultative support for the Maryland Department of Health Center for TB Control and Prevension as well as for IHV's international projects in Botswana, Kenya, and Tanzania. 

Research/Clinical Keywords

Diagnosis and treatment of mycobacterial infections, HIV care and treatment, medical education in resource-limited settings

Highlighted Publications

Saleeb, Paul and Olivier, Kenneth. “Pulmonary nontuberculous mycobacterial disease: New insights into risk factors for susceptibility, epidemiology, and approaches to management in immunocompetent and immunocompromised patients”.  Current Infectious Disease Reports 2010, 12(3): 198-203.

Saleeb PG, Drake SK, Murray PR, et al. “Identification of mycobacteria from solid-culture media by matrix-assisted laser desorption ionization-time of flight mass spectrometry”. Journal of Clinical Microbiology 2011, 49(5): 1790-1794.

Browne SK, Burbelo PD, Chetchotisakd P, Suputtamongkol Y, Kiertiburanakul S, Shaw PA, Kirk JL, Jutivorakool K, Zaman R, Ding L, Hsu AP, Patel SY, Olivier KN, Lulitanond V, Mootsikapun P, Anunnatsiri S, Angkasekwinai N, Sathapatayavongs B, Hsueh P-R, Shieh C-C, Brown MR, Thongnoppakhun W, Claypool R, Sampaio EP, Thepthai C, Waywa D, Dacombe C, Reizes Y, Zelazny AM, Saleeb P, et al. “Adult onset immunodeficiency in Thailand and Taiwan”. New England Journal of Medicine 2012, 367(8): 725-734.

Saleeb PG and Buchwald UK. Update on the epidemiology, diagnosis and therapy of tuberculosis in HIV-infected patients (article in German). Pneumologie 2014, 68(10): 666-75.

Oliver WD, Heil EL, Gonzales JP,  Mehrotra S, Robinett K, Saleeb P, et al. Ceftolozane-tazobactam pharmacokinetics in a critically ill patient on continuous venovenous hemofiltration. Antimicrobial Agents and Chemotherapy2015, 60(3): 1899-1901.

Husson J, Saleeb P, et al. Mycobacterium abscessus: the implications of misidentification in the immunocompromised host. Infectious Diseases in Clinical Practice 2016, 24:e40-42.

Franquiz MJ, Saleeb PG et al. Clinical characteristics of critically ill patients with suspected influenza during the 2009-10 and 2013-14 outbreaks. J Crit Care 2017, 38:73-7.

Sanogo M, Kone B, Diarra B, Maiga M, Baya B, Somboro AM, Sarro YS, Togo AC, Dembele BP, Gita D, Kone A, M’Baye O, Coulibaly N, Diabate S, Traore B, Diallo MH, Coulibaly YI, Saleeb P, et al. Performance of microscopic observation drug susceptibility for the rapid diagnosis of tuberculosis and detection of drug resistance in Bamako, Mali. Clin Microbiol Infect 2017, 23:408.e1-e6.

Oken HA, Saleeb PG, et al. Is Mycobacterium avium paratuberculosis (MAP) the trigger in the Crohn’s Disease spectrum? Open Forum Infect Dis 2017, 4:ofx104.

Peluso MJ, Luckett R, Mantzor S, Bedada AG, Saleeb P, et al. Strengthening medical training programmes by focusing on professional transitions: a national bridging programme to prepare medical school graduates for their role as medical interns in Botswana. BMC Med Educ 2017, 17:261-272.